Logo Image

Shorts

Research and Collaboration in Neuromuscular Medicine
0:51
Research and Collaboration in Neuromuscular Medicine
7 months ago
by
Marco Meglio(+1 more)
MDA 2026: Receiving the MDA Legacy Award
0:51
MDA 2026: Receiving the MDA Legacy Award
7 months ago
by
Michio Hirano, MD(+1 more)
MDA 2026: Future Vision of Neuromuscular Disorders
0:51
MDA 2026: Future Vision of Neuromuscular Disorders
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: Phase 2 ALKIVIA Study
0:31
MDA 2026: Phase 2 ALKIVIA Study
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: In the Shoes of the Patient
0:47
MDA 2026: In the Shoes of the Patient
7 months ago
by
Isabella Ciccone, MPH(+1 more)
MDA 2026: The Future of Precision Medicine
0:51
MDA 2026: The Future of Precision Medicine
7 months ago
by
Isabella Ciccone, MPH(+1 more)
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
1:33
Reasons Behind Eptinezumab's Effectiveness in Treatment-Resistant Migraine
7 months ago
by
Marco Meglio(+1 more)
Managing Neurologic Symptoms During Cancer Treatment
0:56
Managing Neurologic Symptoms During Cancer Treatment
7 months ago
by
Ditte Primdahl, MD(+2 more)
Navigating Neurologic Complications During Cancer Therapy
0:49
Navigating Neurologic Complications During Cancer Therapy
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Primary Care–Neurologist Collaboration After Stroke
1:32
Primary Care–Neurologist Collaboration After Stroke
7 months ago
by
Eva Mistry, MD (+1 more)
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
1:33
Assessing Potential of BD-Tau in Stroke-Related Brain Injury
7 months ago
by
Marco Meglio(+1 more)
Optimizing Immunotherapy in PNS During Cancer Care
0:55
Optimizing Immunotherapy in PNS During Cancer Care
7 months ago
by
Ditte Primdahl, MD(+2 more)
Managing Immunotherapy and Recovery in PNS
0:59
Managing Immunotherapy and Recovery in PNS
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Differentiating PNS From Treatment-Related Neurotoxicity
1:00
Differentiating PNS From Treatment-Related Neurotoxicity
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
1:01
Challenges in Diagnosing Paraneoplastic Neurologic Syndromes
7 months ago
by
Ditte Primdahl, MD(+2 more)
Differentiating Classic PNS from ICI-Related Toxicities
1:11
Differentiating Classic PNS from ICI-Related Toxicities
7 months ago
by
Ditte Primdahl, MD(+2 more)
Managing PNS in the Era of Immunotherapy
0:27
Managing PNS in the Era of Immunotherapy
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Prioritizing Malignancy Screening in Suspected PNS
1:07
Prioritizing Malignancy Screening in Suspected PNS
7 months ago
by
Ditte Primdahl, MD(+2 more)
Screening Strategies for Suspected PNS
0:44
Screening Strategies for Suspected PNS
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Phase 3b RESHAPE Trial Evaluates Switching From Ocrelizumab to Remibrutinib
1:33
Phase 3b RESHAPE Trial Evaluates Switching From Ocrelizumab to Remibrutinib
7 months ago
by
Marisa McGinley, DO(+1 more)
Distinguishing PNS From Other Cancer-Associated Neurologic Complications
0:50
Distinguishing PNS From Other Cancer-Associated Neurologic Complications
7 months ago
by
Ditte Primdahl, MD(+2 more)
Paraneoplastic Neurologic Syndromes at the Crossroads of Care
1:19
Paraneoplastic Neurologic Syndromes at the Crossroads of Care
7 months ago
by
Shailee Samir Shah, MD(+2 more)
Interferon Signaling Pathways in the Brain Associated With MS Initiation
1:38
Interferon Signaling Pathways in the Brain Associated With MS Initiation
7 months ago
by
Louie Pasculli
Evolving Multiple Sclerosis Trials to Better Track Treatment Response
1:33
Evolving Multiple Sclerosis Trials to Better Track Treatment Response
7 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)
Growing Understanding of Duchenne Muscular Dystrophy Pathology
0:56
Growing Understanding of Duchenne Muscular Dystrophy Pathology
7 months ago
by
Jeffrey Chamberlain, PhD(+1 more)
2026 Parkinson Disease Therapeutic Outlook
0:56
2026 Parkinson Disease Therapeutic Outlook
7 months ago
by
Mariana Hernandez Gonzalez-Monje, MD, PhD(+1 more)
Analyzing Phase 3 OCEANIC-STROKE Data
1:33
Analyzing Phase 3 OCEANIC-STROKE Data
7 months ago
by
Andrew Russman, DO(+1 more)
Exploring the Difference Between Pediatric and Adult MS Patients
1:23
Exploring the Difference Between Pediatric and Adult MS Patients
7 months ago
by
Louie Pasculli
Therapies on the Horizon in Multiple Sclerosis
1:24
Therapies on the Horizon in Multiple Sclerosis
8 months ago
by
Katrina Bawden, MSN, MSCN, FNP-C(+1 more)
Using iPSC Models to Predict Multiple Sclerosis Therapeutic Response
1:33
Using iPSC Models to Predict Multiple Sclerosis Therapeutic Response
8 months ago
by
Valentina Fossati, PhD(+1 more)